Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John N Galgiani

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
Antimicrobial Agents and Chemotherapy|April 8, 2009
Pharmacokinetics of nikkomycin Z after single rising oral dosesDavid E Nix, Robert R Swezey, Richard Hector, et al.
Open Forum Infectious Diseases|February 12, 2021
Clinical and Economic Burden of Valley Fever in Arizona: An Incidence-Based Cost-of-Illness AnalysisAmy J Grizzle, Leslie Wilson, David E Nix, et al.
Open Forum Infectious Diseases|April 20, 2018
Top Questions in the Diagnosis and Treatment of CoccidioidomycosisFariba M Donovan, Tirdad T Zangeneh, Joshua Malo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2008
Factors and outcomes associated with the decision to treat primary pulmonary coccidioidomycosisNeil M Ampel, Andrea Giblin, John P Mourani, et al.
Medical Mycology|March 16, 2013
Efficacy of Nikkomycin Z for respiratory coccidioidomycosis in naturally infected dogsLisa F Shubitz, Michael E Roy, David E Nix, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2015
The Return of Delayed-Type Hypersensitivity Skin Testing for CoccidioidomycosisElizabeth E Wack, Neil M Ampel, Rebecca H Sunenshine, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2019
Treatment for Early, Uncomplicated Coccidioidomycosis: What Is Success?John N Galgiani, Janis E Blair, Neil M Ampel, et al.
Emerging Infectious Diseases|January 19, 2017
Risk Factors for Disseminated Coccidioidomycosis, United StatesCamila D Odio, Beatriz E Marciano, John N Galgiani, et al.
Infection and Immunity|October 15, 2008
Vaccine-induced cellular immune responses differ from innate responses in susceptible and resistant strains of mice infected with Coccidioides posadasiiLisa F Shubitz, Sharon M Dial, Robert Perrill, et al.
Annals of the New York Academy of Sciences|March 9, 2007
Nuclear labeling of Coccidioides posadasii with green fluorescent proteinLei Li, Monika Schmelz, Ellen M Kellner, et al.
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Antimicrobial Agents and Chemotherapy|April 8, 2009
Pharmacokinetics of nikkomycin Z after single rising oral dosesDavid E Nix, Robert R Swezey, Richard Hector, et al.
Open Forum Infectious Diseases|February 12, 2021
Clinical and Economic Burden of Valley Fever in Arizona: An Incidence-Based Cost-of-Illness AnalysisAmy J Grizzle, Leslie Wilson, David E Nix, et al.
Open Forum Infectious Diseases|April 20, 2018
Top Questions in the Diagnosis and Treatment of CoccidioidomycosisFariba M Donovan, Tirdad T Zangeneh, Joshua Malo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2008
Factors and outcomes associated with the decision to treat primary pulmonary coccidioidomycosisNeil M Ampel, Andrea Giblin, John P Mourani, et al.
Medical Mycology|March 16, 2013
Efficacy of Nikkomycin Z for respiratory coccidioidomycosis in naturally infected dogsLisa F Shubitz, Michael E Roy, David E Nix, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2015
The Return of Delayed-Type Hypersensitivity Skin Testing for CoccidioidomycosisElizabeth E Wack, Neil M Ampel, Rebecca H Sunenshine, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2019
Treatment for Early, Uncomplicated Coccidioidomycosis: What Is Success?John N Galgiani, Janis E Blair, Neil M Ampel, et al.
Emerging Infectious Diseases|January 19, 2017
Risk Factors for Disseminated Coccidioidomycosis, United StatesCamila D Odio, Beatriz E Marciano, John N Galgiani, et al.
Infection and Immunity|October 15, 2008
Vaccine-induced cellular immune responses differ from innate responses in susceptible and resistant strains of mice infected with Coccidioides posadasiiLisa F Shubitz, Sharon M Dial, Robert Perrill, et al.
Annals of the New York Academy of Sciences|March 9, 2007
Nuclear labeling of Coccidioides posadasii with green fluorescent proteinLei Li, Monika Schmelz, Ellen M Kellner, et al.
Pageof 10